Hang Zhang

发表

Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer.

Baorui Liu, Lixia Yu, Qizhan Liu, 2018, Oncology reports.

The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC

Baorui Liu, Lifeng Wang, Lixia Yu, 2017, Oncotarget.

Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma.

Baorui Liu, Lifeng Wang, Lixia Yu, 2017, Oncology letters.

Enhancement of radiotherapeutic efficacy for esophageal cancer by paclitaxel-loaded red blood cell membrane nanoparticles modified by the recombinant protein anti-EGFR-iRGD

Baorui Liu, Lixia Yu, Jing Yan, 2018, Journal of biomaterials applications.

The role of adhesions between homologous cancer cells in tumor progression and targeted therapy

Baorui Liu, Yiqiao Hu, Rutian Li, 2017, Expert review of anticancer therapy.

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment

Baorui Liu, X. Qian, Lixia Yu, 2018, International journal of nanomedicine.

Detection and monitoring of driver mutations by next‐generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR‐tyrosine kinase inhibitors

Baorui Liu, Lifeng Wang, Yang Yang, 2017, Thoracic cancer.

Tumor‑penetrating peptide fused EGFR single‑domain antibody enhances radiation responses following EGFR inhibition in gastric cancer.

Baorui Liu, Lixia Yu, Qizhan Liu, 2018, Oncology Report.